eFFECTOR Therapeutics CEO Stephen Worland's 2023 pay falls 68% to $1.2M
eFFECTOR Therapeutics reports 2023 executive compensation
By ExecPay News
Published: April 26, 2024
eFFECTOR Therapeutics reported fiscal year 2023 executive compensation information on April 26, 2024.
In 2023, three executives at eFFECTOR Therapeutics received on average a compensation package of $930K, a 49% decrease compared to previous year.
Average pay of disclosed executives at eFFECTOR Therapeutics
Stephen T. Worland, Chief Executive Officer, received $1.2M in total, which decreased by 68% compared to 2022. 49% of Worland's compensation, or $595K, was in salary. Worland also received $238K in non-equity incentive plan, $344K in option awards, as well as $41K in other compensation.
Michael Byrnes, Chief Financial Officer, received a compensation package of $827K, which decreased by 58% compared to previous year. 54% of the compensation package, or $450K, was in salary.
Douglas Warner, Chief Medical Officer, earned $746K in 2023, a 5% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 26, 2024.